Page last updated: 2024-10-30

ketotifen and Visceral Pain

ketotifen has been researched along with Visceral Pain in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Visceral Pain: Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, D1
Zhu, J1
Zhu, M1
Wei, K1
Chen, Q1
Wu, X1
Miao, X1
Lu, Z1

Other Studies

1 other study available for ketotifen and Visceral Pain

ArticleYear
Inhibition of Mast Cell Degranulation Relieves Visceral Hypersensitivity Induced by Pancreatic Carcinoma in Mice.
    Journal of molecular neuroscience : MN, 2019, Volume: 69, Issue:2

    Topics: Adult; Animals; Cancer Pain; Carcinoma; Cell Degranulation; Female; Histamine; Histamine H1 Antagoni

2019